Antibody Therapeutics for Life

Notices

PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine and Dr. Sung Woo Kim, Head of Business Development are attending BIO 2018.
  • Written by Admin
  • Written date 2019-01-14 11:36:15
  • Inquire 1698

PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine and Dr. Sung Woo Kim, Head of Business Development are attending BIO 2018 (http://convention.bio.org/2018/).

 

 

For investors attending the BIO 2018, please contact PharmAbcine Investor Relations and business development to schedule a meeting with management 

at sungwoo.kim@pharmabcine.com.

List





Prev PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. ...
Next PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. ...